Skip to main content

Goodman Corey S

In the past year, 1 open-market purchase filing worth $5.00M and no sales.

Current role at each company

Show 2 more companies

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
$5.00M
1 filing
Sold
–
0 filings
Net
+$5.00M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Goodman Corey S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

ALXO Alx Oncology Holdings Inc

Director, 10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 4, 2026 (view filing)Feb 22 daysGoodman Corey SDirector, 10% OwnerPPurchase+3.18M$1.57+$5.00M+60.5%8.45M after

ARTV Artiva Biotherapeutics, Inc.

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 22, 2024 (view filing)8:26 PM ETJul 22Same dayGoodman Corey S and 4 others10% OwnerPPurchase+416.7K$12.00+$5.00M+27.4%1.94M after

Elevation Oncology, Inc.

10% Owner2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 27, 2022 (view filing)7:20 PM ETMay 252 daysGoodman Corey S and 4 others10% OwnerSSale−702.7K$4.12−$2.90M−26.9%1.91M after
Jul 1, 2021 (view filing)5:27 PM ETJun 292 daysGoodman Corey S and 4 others10% OwnerPPurchase+625.0K$16.00+$10.0M+31.5%2.61M after

CMPI Checkmate Pharmaceuticals, Inc.

10% Owner7 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 17, 2022 (view filing)5:12 PM ETMay 13-164 daysGoodman Corey S and 4 others10% OwnerSSale−131.7K$10.45−$1.38M−5.8%2.16M after2 lots
May 12, 2022 (view filing)8:47 PM ETMay 10-122 daysGoodman Corey S and 4 others10% OwnerSSale−160.9K$10.39−$1.67M−6.6%2.29M after3 lots
May 9, 2022 (view filing)6:58 PM ETMay 5-94 daysGoodman Corey S and 4 others10% OwnerSSale−86.7K$10.37−$898.9K−3.4%2.45M after3 lots
May 4, 2022 (view filing)7:30 PM ETMay 2-42 daysGoodman Corey S and 4 others10% OwnerSSale−270.7K$10.38−$2.81M−9.6%2.54M after3 lots
Apr 29, 2022 (view filing)5:50 PM ETApr 27-292 daysGoodman Corey S and 4 others10% OwnerSSale−190.0K$10.38−$1.97M−6.3%2.81M after3 lots
Apr 26, 2022 (view filing)6:40 PM ETApr 22-264 daysGoodman Corey S and 4 others10% OwnerSSale−129.8K$10.39−$1.35M−4.2%3.00M after3 lots
Apr 21, 2022 (view filing)8:54 PM ETApr 19-212 daysGoodman Corey S and 4 others10% OwnerSSale−547.7K$10.41−$5.70M−14.9%3.13M after3 lots

MTCR Metacrine, Inc.

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 26, 2021 (view filing)4:35 PM ETOct 22-254 daysGoodman Corey S and 4 others10% OwnerSSale−615.7K$1.51−$928.9K−20.1%2.44M after2 lots

VTYX Ventyx Biosciences, Inc.

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 25, 2021 (view filing)7:40 PM ETOct 25Same dayGoodman Corey S and 4 others10% Owner, Other: See RemarksPPurchase+312.5K$16.00+$5.00M+8.5%4.00M afterDuplicate filing